Role of α2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage
- 1 January 1979
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 16 (3-4) , 393-400
- https://doi.org/10.1016/0049-3848(79)90086-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Natural inhibitors of fibrinolysisProgress in Cardiovascular Diseases, 1979
- THROMBOLYTIC THERAPYBritish Medical Bulletin, 1978
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states.Journal of Clinical Investigation, 1977
- Threshold phenomena in blood fibrinolysisThrombosis Research, 1977
- The primary inhibitor of plasmin in human plasmaBiochemical Journal, 1976
- Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human PlasmaEuropean Journal of Biochemistry, 1976
- α2-Macroglobulin,α1-Antitrypsin, and Antithrombin III in Plasma and Serum during Fibrinolytic Therapy with UrokinaseScandinavian Journal of Clinical and Laboratory Investigation, 1972
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. II. CLINICAL OBSERVATIONS ON PATIENTS WITH MYOCARDIAL INFARCTION AND OTHER THROMBOEMBOLIC DISORDERS*†Journal of Clinical Investigation, 1959
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*Journal of Clinical Investigation, 1959
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952